Loading organizations...
§ Private Profile · Woodland Hills, CA, USA
Medical technology company developing AI-powered autonomous eye screening for diabetic retinopathy and other blinding eye diseases.
Eyenuk is a Woodland Hills, California-based medical technology company that develops artificial intelligence software for autonomous eye disease screening and predictive risk assessment. The organization utilizes computer vision and deep learning algorithms through its flagship EyeArt platform to detect conditions such as diabetic retinopathy and age-related macular degeneration from standard retinal images. Operating with a current team of 27 employees and generating under $5 million in annual revenue, the enterprise provides its diagnostic tools directly to healthcare providers and specialized ophthalmology clinics. To support its operations, Eyenuk has raised over $43 million in total venture funding, including a $26 million Series A financing round backed by institutional investors AXA IM Alts and T&W Medical. Currently led by Chief Executive Officer Gaurav Agarwal and Board Chairman Mads Dall, Eyenuk was founded in 2010 by Kaushal Solanki.
Eyenuk has raised $32.2M across 2 funding rounds.
Eyenuk has raised $32.2M in total across 2 funding rounds.
Eyenuk has raised $32.2M across 2 funding rounds. Most recently, it raised $26.0M Series A in October 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Oct 17, 2022 | $26M Series A | AXA IM Alts | A&C Foelsgaard Alternativer, Kendall Capital Partners, KOFA Healthcare, Marie Louise Little | Announced |
| Jul 26, 2021 | $6.2M Venture Round | Zina Affas Besse | — | Announced |
Eyenuk has raised $32.2M in total across 2 funding rounds.
Eyenuk's investors include AXA IM Alts, A&C Foelsgaard Alternativer, Kendall Capital Partners, KOFA Healthcare, Marie-Louise Little, Zina Affas Besse.